Crystalline pyrazole derivative
Details for Australian Patent Application No. 2005227745 (hide)
International Classifications
Event Publications
28 September 2006 PCT application entered the National Phase
PCT publication WO2005/095349 Priority application(s): WO2005/095349
29 May 2008 Application Accepted
Published as AU-B-2005227745
25 September 2008 Standard Patent Sealed
16 October 2008 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 02 Jun 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
26 February 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 02 Jun 2008
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005227749-Sulfonamide compounds for the treatment of neurodegenerative disorders
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser